Cannabinoids facilitate the swallowing reflex elicited by the superior laryngeal nerve stimulation in rats. by Zakir, HM
Cannabinoids Facilitate the Swallowing Reflex Elicited by
the Superior Laryngeal Nerve Stimulation in Rats
Rahman Md. Mostafeezur., Hossain Md. Zakir., Hanako Takatsuji, Yoshiaki Yamada,
Kensuke Yamamura, Junichi Kitagawa*
Division of Oral Physiology, Department of Oral Biological Science, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
Abstract
Cannabinoids have been reported to be involved in affecting various biological functions through binding with cannabinoid
receptors type 1 (CB1) and 2 (CB2). The present study was designed to investigate whether swallowing, an essential
component of feeding behavior, is modulated after the administration of cannabinoid. The swallowing reflex evoked by the
repetitive electrical stimulation of the superior laryngeal nerve in rats was recorded before and after the administration of
the cannabinoid receptor agonist, WIN 55-212-2 (WIN), with or without CB1 or CB2 antagonist. The onset latency of the first
swallow and the time intervals between swallows were analyzed. The onset latency and the intervals between swallows
were shorter after the intravenous administration of WIN, and the strength of effect of WIN was dose-dependent. Although
the intravenous administration of CB1 antagonist prior to intravenous administration of WIN blocked the effect of WIN, the
administration of CB2 antagonist did not block the effect of WIN. The microinjection of the CB1 receptor antagonist directly
into the nucleus tractus solitarius (NTS) prior to intravenous administration of WIN also blocked the effect of WIN.
Immunofluorescence histochemistry was conducted to assess the co-localization of CB1 receptor immunoreactivity to
glutamic acid decarboxylase 67 (GAD67) or glutamate in the NTS. CB1 receptor was co-localized more with GAD67 than
glutamate in the NTS. These findings suggest that cannabinoids facilitate the swallowing reflex via CB1 receptors.
Cannabinoids may attenuate the tonic inhibitory effect of GABA (gamma-aminobuteric acid) neurons in the central pattern
generator for swallowing.
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Introduction
Cannabinoids (terpenophenolic compounds found in the
Cannabis plant, Cannabis sativa) have been reported to affect
multiple biological functions including appetite, food intake and
energy metabolism [1,2,3,4]. Investigations into the biological
basis of the multiple effects of cannabinoid have yielded important
breakthroughs in recent years. One such fact is that the actions of
cannabinoids are mediated by binding with specific receptors
namely the cannabinoid receptor 1 (CB1) and cannabinoid
receptor 2 (CB2). Various reports have described the critical role
of cannabinoids and their endogenous ligands which regulate
energy balance and food intake via CB1 receptors of the
hypothalamus and limbic structures in the central nervous system
(CNS), and through mechanisms involved in adipose tissue and the
intestinal system in the periphery [2,5,6]. CB1 receptors are found
abundantly throughout the CNS including in the brainstem [7,8],
whereas CB2 receptors are found primarily in the immune system
[9,10]. The Brainstem CB1 receptors are mostly located in areas
relevant to feeding, such as the nucleus tractus solitarius (NTS) and
other nuclei of the dorsal vagal complex (DVC) [11,12,13,14,15].
Several studies have revealed the functional role of CB1 receptors
in the DVC in regulating the gastrointestinal autonomic functions
including gastrointestinal vagal reflexes. For example, CB1
receptors regulate the cannabinoid-mediated anti-emetic effects
[14,15,16,17] and digestive motor activity [18,19], and inhibit
transient lower esophageal sphincter relaxations [12,20,21].
However, the functional role of CB1 receptors in the NTS in
this respect is still elusive.
Swallowing is an essential motor component of feeding behavior
and is a complex reflex that causes the propulsion of food from the
oral cavity into the stomach through the pharynx and esophagus
[22]. It is generally well known that swallowing generated by the
central pattern generator is located in the NTS [22]. Because of
the presence of CB1 receptors in the NTS and the involvement of
CB1 receptors in gastrointestinal autonomic functions, we
hypothesized that cannabinoids may play crucial role in regulating
the swallowing function, and that the action of cannabinoid is
mediated by the binding of CB1 receptors in NTS. Based on this
assumption we evaluated the effect of the cannabinoid receptor
agonist (WIN 55,212-2) on the swallowing reflex elicited by
electrical stimulation of the superior laryngeal nerve (SLN), a
branch of the vagus nerve [23,24,25,26,27], in anesthetized rats.
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In the present study we have demonstrated that cannabinoid
facilitate the swallowing reflex elicited by electrical stimulation of
the SLN, and that the facilitatory effect of cannabinoid may be
mediated by CB1 receptors.
Methods
Animal Preparation
A total of 75 male Sprague-Dawley rats weighing 250–300 g
were used in the present study. The experiments were carried out
in accordance with the ‘‘Principles of Laboratory Animal Care’’
(NIH publication #86-23, revised 1996). The animal protocols
were approved by the Intramural Animal Care and Veterinary
Science Committee of Niigata University.
The rats were deeply anesthetized with urethane (1.0–1.5 g/kg,
administered intraperitoneally). The adequacy of the anesthesia
was checked by noxious pressing the hind paw in order to
determine if a withdrawal reflex was evoked, and if so, a
supplementary dose of urethane was given. After the anesthesia,
the rats were fixed in the supine position with adhesive tape and
their body temperatures were maintained at 36–37uC with a
heating pad. For intravenous infusion of the drugs, the femoral
vein was exposed, and then a plastic infusion tube was implanted
through the femoral vein. A midline incision was made in the
ventral surface of the neck, and the trachea was cannulated to
maintain respiration. To record EMG activity, the mylohyoid
muscle was exposed and a pair of bipolar electromyographic
(EMG) electrodes (Enamel-Nichrome wire) was implanted in the
exposed mylohyoid muscle. Swallowing was identified by EMG
activity of the mylohyoid muscle and by visual observation of
laryngeal movement. Unilateral SLN was exposed by blunt
dissection of the sternothyroid muscle and bipolar platinum wire
electrodes were fixed onto the central cut end of the SLN. Liquid
silicone was poured over the muscle and electrodes to fix the
electrode with the nerve. Additionally, silicone prevents the
dryness of the nerve, and allowing the nerve to be used for a
long term experiment.
Nerve Stimulation to Evoking Swallowing Reflex and the
Intravenous Infusion of Drugs
First, the SLN in naı¨ve rats was stimulated by repetitive
electrical stimulation with various stimulus intensity (intensity: 3–
15 mA, frequency: 20 Hz, duration: 1.0 ms) in order to investigate
relationships between the intensity of electrical stimulation and the
properties of the swallowing reflex (Fig. 1A). After measuring the
relationship of the stimulus intensity to onset latency and intervals
between the swallowing reflexes, the parameter of the electrical
stimulation (intensity: 4–5 mA, frequency: 20 Hz, duration:
1.0 ms) was adjusted to keep the onset latency for the first swallow
between 1 and 1.5 s for the experiment (Fig. 2A). The swallowing
reflexes were evoked before and after the drug infusion and
electrical stimulation was discontinued after three consecutive
swallows were evoked for each time point (Fig. 2C and 2D). The
onset latency of the first swallow and the time interval between
swallow was analyzed. The onset latency of the first swallow was
defined as the time required for evoking the first swallow after the
onset of electrical stimulation. The time intervals between the first
and second swallows and second and third swallows were averaged
and the averaged time was considered the time interval between
swallows. The onset latency of the first swallow and the time
interval between swallows were averaged from three electrical
stimulations.
The onset latency of the first swallow and the time interval
between swallows calculated were measured before and after
intravenous infusion of the drugs or vehicle (see Fig. 1B, 1C and
1D).
Drugs and Chemicals
To investigate the dose dependent effect of the cannabinoid, the
cannabinoid receptor agonist, WIN 55,212-2 (Sigma-Aldrich,
USA), was used at various concentrations (60, 30 and 15 nmol/
kg). The CB1 receptor antagonist, AM 251 (120 nmol/kg as
pretreatment, 120, 250 and 500 nmol/kg when used alone, in
addition, 12 pmol in 100 nl to use microinjection), and the CB2
receptor antagonist, AM 630 (500 nmol/kg), were both acquired
Wako Pure Chemical Industries, Ltd. (Osaka, Japan). The drugs
were made up in vehicle comprising ethanol (5%), Tween-80
(10%), and normal saline (85%). The drugs were infused at a
volume of 1 ml/kg.
Microinjection into the NTS
To investigate the role of CB1 receptors in the NTS, the drugs
were microinjected into the NTS. For this experiment, the animals
were placed in the prone position and a craniotomy was
performed to expose the NTS. However, in the prone position,
it was difficult to keep an electrode fixed in order to stimulate the
SLN. Therefore, we initially microinjected the CB1 receptor
antagonist into the NTS in the supine position, and then
intravenously administered the CB1 receptor agonist after setting
up of the electrode for SLN stimulation in the prone position.
Rats were fixed in the prone position using the stereotaxic
frame. The CB1 receptor antagonist, AM 251 (12 pmol, 100 nl)
was microinjected stereotaxically in the central pattern generator
of swallowing, which is located in the region of the STN extending
between 0.5 and 0.7 mm rostral to the caudal edge of the area
postrema (taken as 0), 0.6–0.8 mm laterally, and 0.6–0.8 mm in
depth, according to a previous study [28]. The rats were then
placed in the supine position and the CB1 receptor agonist, WIN
55,212-2 (30 nmol/kg), was intravenously administered 15 min
after the microinjection of AM 251 into the NTS. By this time, we
had also placed stimulating electrodes on the SLN. The SLN was
stimulated electrically to elicit the swallowing reflex (intensity: 4–
5 mA, frequency: 20 Hz, duration: 1.0 ms) (Fig. 1). The effect of
this stimulus on the swallowing reflex was intended to elicit the
onset latency of 1–1.5 s in naı¨ve rats (Fig. 2A). As the contrast
experiment, the vehicle (100 nl) was microinjected into the NTS
before the intravenous infusion of WIN 55,212-2 (30 nmol/kg)
(Fig. 1).
The onset latency and intervals between evoked swallows were
analyzed at different time points for 3 h.
Immunohistochemistry
For double immunofluorescence histochemistry, rats were
deeply anesthetized with sodium pentobarbital and perfused with
200 ml of phosphate-buffered saline (PBS) followed by 500 ml of
4% paraformaldehyde. The hindbrain was removed and post-
fixed in the same fixative for 2 days and was then transferred to
20% sucrose (w/v) in PBS for several days to ensure effective
cryoprotection. Sections (30 mm) were cut on a freezing microtome
and were collected in PBS. Free-floating tissue sections were rinsed
in PBS and blocked with 10% normal goat serum (NGS) in 0.3%
Triton X-100 for 1 h to prevent non-specific staining. The sections
were then incubated with rabbit polyclonal anti-CB1 receptor
antibody (1:200; Abcam, USA) and either mouse monoclonal anti-
GAD67 antibody (1:600; Sigma, USA) or mouse anti-glutamate
antibody (1:600, Millipore, USA) in 3% NGS and 0.3% Triton X-
100 at 4uC for 48 h. After washing in PBS, the sections were
incubated with Alexa Flour 488 goat anti-rabbit IgG (1:1000,
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Invitrogen, USA) and Alexa Flour 568 goat anti-mouse IgG
(1:200, Invitrogen, USA) for 2 h. Sections were subsequently
washed in PBS, mounted on slides and coverslipped with
VECTASHIELD Mounting Medium (Vector Lab., USA). Images
of immunofluoresence staining were photographed with a camera
attached to a fluorescent microscope (Biozero 8000, Keyence
Corp., Japan).
Co-localization of CB1 receptor immunoreactivity in glutamic
acid decarboxylase 67 (GAD67)-immunoreactive (ir) or glutamate-
ir cells was assessed throughout the NTS. To understand the
rostrocaudal distribution of CB1 receptors in the gamma-
aminobutyric acid (GABA)ergic and glutamatergic neurons,
sections were compared with the Chemoarcitectonic Atlas of the
Rat Brainstem [29] and divided into four rostrocaudal levels: most
rostral, rostral, intermediate, and caudal. Similar divisions have
been made in previous studies [30,31]. The most rostral level was
approximately between bregma –12.36 mm and bregma –
12.84 mm and the rostral level was approximately between
bregma –12.84 mm and bregma –13.56 mm. The intermediate
level was at the level of the area postrema, approximately between
bregma–13.56 mm and bregma –14.16 mm. The caudal level was
defined as the level caudal to the area postrema, between bregma
–14.16 mm and bregma –14.65 mm. To assess the co-localization
CB1 receptors with GAD67 or glutamate, double labeled cells
were identified and analyzed using a BZ-8000 system (Keyence,
Osaka, Japan). The ir-cells showing staining two times more
intense than the average background (yellow labeled cells) were
considered positive for co-localization. Three sections were
randomly chosen from each level and the number of GAD67-ir
and glutamate-ir cells in which CB1 receptor immunoreactivity
co-localized were counted throughout the rostrocaudal axis or the
lateral and medial portion of the NTS, using Image J software
(NIH, USA). The average of the 3 sections was used for statistical
analysis.
Statistical Analysis
The pre-infusion data was compared with post-infusion data
using ANOVA followed by Dunnett’s post-hoc test. ANOVA
followed by Student-Newman-Keuls post-hoc test were per-
formed when comparing the data for the effects of the different
doses on WIN 55,212-2. The immunohistochemical data was
compared using the Student’s t-test. Data are expressed as mean
6 SD.
Figure 1. Schematic illustration of the present experimental protocol. The experimental procedure to investigate relationships between the
intensity of electrical stimulation and the swallowing reflex (A). The time-course of recording points for the swallowing reflexes before and after
intravenous infusion (B and C) of drugs or vehicle and microinjection of drugs into the NTS (D). R: recording 3swallows evoked by the SLN stimulation,
WIN: WIN 55,212-2, CB1 ant: AM 251, CB2 ant.: AM 630, i.v.: intravenous infusion.
doi:10.1371/journal.pone.0050703.g001
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Results
Effect of the Cannabinoid Receptor Agonist, WIN 55,212-
2, on the Swallowing Reflex
To determine the electrical stimulus intensity, we analyzed the
relationship between stimulus intensity with the onset latency and
interval of the swallowing reflex in naı¨ve rats (Fig. 2A and 2B).
Both onset latency and interval decreased with increased stimulus
intensity. It was observed that onset latency decreased at around 1
to 1.5 s at 4–5 mA, (the ellipses in Fig. 2A and 2B). Although the
onset latency of the swallowing decreased with increased stimulus
intensity, changes in the swallowing latency due to stimulus
intensity 7–15 mA were not significantly different. Therefore, we
decided to use the stimulus intensity 4 to 5 mA in the present study.
The swallowing reflex was evoked before and after infusion of
the drugs in anesthetized rats. Typical examples of the facilitation
of the swallowing reflex after the intravenous infusion of WIN
55,212-2 (60 nmol/kg) is shown in Fig. 2C and 2D. Before the
intravenous infusion of WIN 55,212-2, the onset latency and
interval were 1.46 s and 2.62 s, respectively (Fig. 2C). Two hours
after the intravenous infusion of WIN 55,212-2 (60 nmol/kg), the
onset latency and interval decreased to 0.45 s and 0.85 s,
respectively (Fig. 2D).
Figure 3 shows the effect of different doses of the intravenous
infusion of WIN 55,212-2 on the onset latency of the first swallow
and the intervals between swallows. The effect of WIN 55,212-2
on the swallowing reflex was specific (the vehicle alone did not
alter either the onset latency or the interval) and dose-dependent
(Fig. 3). The facilitatory effects of WIN 55,212-2 on the latency
and the interval of the swallowing reflex were observed. At dose of
60 nmol/kg, the onset latency (Fig. 3A) and interval (Fig. 3B)
significantly decreased 30 min after the intravenous infusion of
WIN 55,212-2. The strong facilitatory effect of WIN 55,212-2 was
observed 1 h after infusion, and the effect persisted at least 7 h
after the infusion of WIN 55,212-2. After treatment with WIN
55,212-2 at a dose of 30 nmol/kg, the onset latency significantly
decreased from 1 h to 4 h after infusion (Fig. 3A). In addition, the
interval was significantly decreased from 30 min to 4 h after the
infusion, but returned to pre-infusion levels after 4 h of infusion
(Fig. 3B). At the 15 nmol/kg dose, the onset latency and interval
were significantly decreased only from 1 h to 2 h after infusion of
WIN 55,212-2. Significant differences were also observed in the
onset latency and interval at various time points between the doses
of 60 nmol/kg and 30 nmol/kg, and between 30 nmol/kg and
15 nmol/kg (Fig. 3).
Figure 2. Example of facilitation of the electrically-stimulated swallowing reflex by the cannabinoid agonist, WIN 55,212-2. The
onset latency to the first swallow (A) and intervals between swallows (B) induced by different intensities of electrical stimulation of the SLN of naı¨ve
rats (n = 5). The ellipses indicate the characteristics of the swallowing reflex by the electrical stimulation at 4–5 mA. The typical example that the
swallowing reflex by the SLN stimulation before (C), and two hours after (D), infusion of WIN 55,212-2. Note that WIN 55,212-2 decreases the onset
latency to the first swallow and the intervals between swallows.
doi:10.1371/journal.pone.0050703.g002
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Effect of Pretreatment with CB1 or CB2 Antagonist on the
Swallowing Reflex
To investigate whether the facilitatory effect of WIN 55,212-2 is
mediated through the CB1 or CB2 receptors, CB1 and CB2
receptor antagonist was administrated prior to WIN 55,212-2.
When the CB1 receptor antagonist (AM 251: 120 nmol/kg) was
intravenously administered 15 min prior to infusion of WIN
55,212-2 (30 nmol/kg), the facilitatory effect of WIN 55,212-2 on
the swallowing reflex was attenuated and no significant modula-
tion of the swallowing reflex was observed over a 3 h period
(Fig. 4). In contrast, when the CB2 receptor antagonist (AM 630:
500 nmol/kg) was intravenously administered 15 min prior to
infusion of WIN 55,212-2 (30 nmol/kg), the WIN 55,212-2-
mediated facilitation of the swallowing reflex was preserved (Fig. 4).
In addition, data was rerecorded for 3 h following intravenous
administration of the CB1 receptor antagonist (AM 251: 120, 250
and 500 nmol/kg) or CB2 (AM 630: 500 nmol/kg) alone. There
was no significant influence on the onset latency or interval of the
swallowing reflex as compared with those observed before
treatment (Fig. 4).
Microinjection of the CB1 Receptor Antagonist into the
NTS Prior to Intravenous Infusion of WIN 55,212-2
In order to investigate the possible role of the CB1 receptors in
the NTS in the facilitation of swallowing after intravenous infusion
of WIN 55,212-2, CB1 antagonist (AM 251: 12 pmol, 100 nl) or
vehicle (100 nl) was microinjected into the NTS 15 min before
WIN 55,212-2 administration. Figure 5A and 5B shows the onset
latency of the first, and the intervals between swallows. As
mentioned in the intravenous administration of CB1 antagonist,
the microinjection of CB1 antagonist into the NTS also completely
blocked the effect of WIN 55,212-2, and there was no significant
facilitation in latency or interval of the swallowing reflex.
However, the microinjection of vehicle (100 nl) of AM 251 into
the NTS did not block the effect of WIN 55,212-2, and there was a
significant facilitatory effect of WIN 55,212-2 on the latency and
interval of the swallowing. The location of the microinjection
within the NTS was confirmed by adding 4% pontamine sky blue
with AM 251 or the vehicle in all rats, and the histology of the
brainstem was conducted for localization of the injection site. In all
rats, the injection site was localized within the NTS (Fig. 5C).
Figure 3. Effect of different doses of cannabinoid receptor agonist on the onset latency to the first swallow and intervals between
swallows. Graphs demonstrating the effect of WIN 55,212-2 on the onset latency to the first (A) and intervals between electrically stimulated
swallows (B). Dose-dependent facilitation of the electrically stimulated swallows by WIN 55,212-2 was observed. Data are presented as percentage of
pre-infusion data and n = 5 for each group.
doi:10.1371/journal.pone.0050703.g003
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Co-localization of CB1 Receptor Immunoreactivity with
GAD67- and Glutamate-ir Cells in the NTS
Figure 6A illustrates the rat brainstem sections divided into four
rostrocaudal levels (the most rostral, rostral, intermediate and
caudal). The mosaic patterned areas in Fig. 6A and 6B indicate the
intermediate levels, respectively. A double immunofluorescence
histochemical study was conducted to visualize CB1 receptor
immunoreactivity, GAD67- and glutamate-ir cells in the NTS.
Typical pictures of the intermediate level show CB1 receptor
immunoreactivity (Fig. 6Ca and 6Da), GAD67-ir cells (Fig. 6Cb)
and glutamate-ir cells (Fig. 6Db) in the NTS. CB1 receptor
immunoreactivity was found to be co-localized with GAD67- ir
cells (Fig. 6Cc and 6Cc1) and glutamate-ir cells (Fig. 6Dc and
6Dc1) in the NTS. We analyzed the number of co-localization of
CB1 receptor immunoreactivity with GAD67- and gulutamate-ir
cells throughout the rostrocaudal axis or the lateral and medial
portion of the NTS. Co-localization occurred significantly more in
GAD67-ir than glutamate-ir cells throughout the rostrocaudal axis
of the NTS (Fig. 7A). Moreover, co-localization of CB1 with
GAD67- ir cells was found more prevalent than that of CB1 with
gulutamate-ir cells in the lateral portion of the NTS (Fig. 7B).
Discussion
The present study shows that the cannabinoid receptor agonist,
WIN 55,212-2, enhances the swallowing reflex elicited by
electrical stimulation of the SLN. The duration of the effect of
WIN 55,212-2 on the electrically stimulated swallowing reflex was
dose-dependent. The onset latency of the first swallow and the
interval between swallows was significantly shorter in rats which
received higher doses of WIN 55,212-2 than those in the lower
dose group. Immunohistochemical studies have revealed that CB1
receptors are located in the NTS where they co-localize more with
GABAergic neurons than with glutamatergic neurons. In addition,
in the lateral part of the NTS a significantly greater number of the
GABAergic neurons with CB1 receptors were found than
glutamatergic neurons with CB1 receptors.
Electrical stimulation of the SLN reliably elicits the swallow-
ing reflex [23,24,25,26,27]. Afferents fibers of the SLN project
Figure 4. Effect of different doses of cannabinoid receptor antagonists on the onset latency to the first swallow and intervals
between swallows. Graphs demonstrating the effect of combination of WIN 55,212-2 and cannabinoid (CB1 or CB2) receptor antagonists, and
different doses of cannabinoid receptor antagonists on the onset latency to the first (A) and intervals between (B) electrically stimulated swallows.
Pretreatment with a CB1 receptor antagonist blocked the effect of WIN 55,212-2, whereas pretreatment with a CB2 receptor antagonist did not. The
CB1 antagonist alone and the vehicle had no significant effect on the swallowing reflex. Data are presented as percentage of pre-infusion data and
n = 5 for each group. CB1 ant: CB1 receptor antagonist (AM 251), CB2 ant.: CB2 receptor antagonist (AM 630).
doi:10.1371/journal.pone.0050703.g004
Cannabinoids Facilitate the Swallowing Reflex
PLOS ONE | www.plosone.org 6 November 2012 | Volume 7 | Issue 11 | e50703
to the NTS [22,32]. Several reports indicate that NTS neurons
play a leading role in the generation of swallowing [22].
Sequential and rhythmic firing of neurons in the NTS have
been shown to parallel the motor pattern of swallowing
[33,34,35]. Pre-swallowing neuronal activity is also located
mostly within the NTS [22]. Moreover, systematic studies of the
brainstem indicate that central areas responsible for swallowing
are situated in the region of the NTS [33,36]. Modulation of
the swallowing reflex using fine microinjections of drugs into the
NTS also provides firm evidence that the central pattern
generator of swallowing is located in the NTS [37,38,39,40]. In
the present study we also observation that NTS may play a
major role in the modulation of the swallowing reflex after the
administration of cannabinoid.
It has been postulated that the lateral portion of the NTS
comprising the intermediate, central, interstitial, ventral and
ventrolateral subdivisions of the nucleus may be involved in the
triggering and programming of swallowing [22,33,41,42]. How-
ever, complex neuronal connections exist among the various
subnuclei of the NTS [35,41,43], suggesting the involvement and
integration of neurons of different subnuclei. Several neurotrans-
mitter systems have been reported to play a role in the swallowing
mechanism [22,44,45]. Among them, glutamatergic and GA-
BAergic neurons play a major role. In consideration of the present
Figure 5. Effect of microinjection of CB1 receptor antagonist (AM 251) into the NTS prior to intravenous infusion of WIN 55,212-2.
Microinjection of AM251 blocked the enhancement of the onset latency to the first swallow (A) or the intervals between swallows (B) in the
swallowing reflex by WIN 55,212-2 intravenous infusion. Note that the facilitatory effect of WIN 55,212-2 on electrically stimulated swallows was
persisted after the microinjection of vehicle in NTS. The photomicrograph of the microinjection site of drugs in the NTS (C). WIN: WIN 55,212-2, CB1
ant.: CB1 receptor antagonist (AM 251).
doi:10.1371/journal.pone.0050703.g005
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study, it is possible that lateral portion of the NTS is involved in
the facilitation of the swallowing reflex mechanism.
Some recent studies have reported that endogenous cannabi-
noid (2-arachidonoylglycerol: 2-AG) is synthesized in, and released
from post-synaptic neurons. The binding of 2-AG to CB1
receptors on pre-synaptic neurons causes suppression of neuro-
transmitter release. This novel neuroregulatory system is called
‘‘Retrograde suppression of synaptic transmission’’ [46,47].
In the present study, we observed that the non-selective
cannabinoid receptor agonist WIN 55,212-2 facilitated the
electrically stimulated swallowing reflex in a dose-dependent
manner. When the CB2 receptor antagonist, AM 630, was infused
prior to WIN 55,212-2, the facilitation of the electrically
stimulated swallowing reflex was unaffected. In contrast, pretreat-
ment with the highly selective CB1 receptor antagonist AM 251
effectively blocked the effect of WIN 55,212-2. In addition, the
dose-response study of AM 251 (120, 250 and 500 nmol/kg) had
no significant influence on the onset latency and interval time of
the swallowing reflex induced by electrical stimulation as
compared with those observed before treatment. Together, these
results strongly suggest that the action of WIN 55,212-2 is
mediated by CB1 receptors. However, infusion of the CB1
receptor antagonist alone did not have any effect on swallowing.
CB1 receptor antagonists administered alone have previously been
found to produce no effect in many studies where antinociceptive
or antiemetic effects of cannabinoids were investigated
[14,15,16,48,49,50,51,52,53]. From the above observations, it
can be assumed that WIN 55,212-2 binds to pre-synaptic CB1
receptors, and results in the suppression of neurotransmitter
release. Intravenously infused drugs spread to various areas of the
brain and periphery. The central pattern generator of swallowing
located in the NTS receives input from peripheral afferents and
various supramedullary areas [22]. The above observation is
supported by the present findings that the intravenous infusion of
WIN 55,212-2 modulates the swallowing reflex. However, the
modulatory effect of WIN 55,212-2 was blocked by microinjection
of CB1 antagonist in the NTS. The present study shows that the
effect of WIN 55,212-2 on the swallowing reflex is probably
expressed in the central pattern generator of swallowing in the
NTS.
Previous studies have reported that CB1 receptors were present
in the NTS [8,12,14]. Regarding this, Partosoedarso and
collaborators (2003) showed that vagotomy or nodose ganglion-
ectomy did not alter the expression of the CB1 receptor in the
DVC of ferret, including in the NTS. Consistent with the above
findings, our immunohistochemical study also showed that CB1
receptors are abundant in the NTS.
Regarding neurotransmitter involvement, we have found higher
co-localization of CB1 receptors with GABAergic neurons than
with glutamatergic neurons, suggesting that cannabinoids may
have a greater inhibitory effect on GABA release than on
glutamate release in the NTS. Therefore, the excitatory effects
are higher than the inhibitory effects which may result in the
facilitation of the swallowing reflex. Moreover, expression of CB1
receptors was observed in more GABAergic and glutamatergic
neurons in the lateral portion of the NTS, the area that been
particularly implicated in the process of swallowing. The present
study suggests that the mechanism by which WIN 55,212-2
enhances the electrically stimulated swallowing reflex may include
the attenuation of tonic GABAergic input in the lateral portion of
the NTS. Another study using brainstem slices showed that both
inhibitory and excitatory synaptic inputs in the dorsal motor
Figure 6. Photomicrographs of immunoreactivity for CB1, GAD67 and glutamate in the NTS. The illustrations show the intermediate area
(the mosaic and beige colored part) divided into four rostrocaudal levels in the NTS (A and B). Photomicrographs of immunoreactivity for CB1
receptors (Ca and Da), GAD67 (Cb), glutamate (Db), CB1 receptors + GAD67 (Cc) and CB1 receptors + glutamate (Dc) in the NTS. The left and right
area surrounded by the broken line in Ca, Cb, Cc and Da, Db, Dc indicates the lateral and medial portion of the NTS, respectively. The small square
boxes in Cc and Dc shows the area of the high magnified images that in Cc1 and Dc1. High magnified images demonstrating co-localization of CB1
receptors + GAD67 and CB1 receptors + glutamate are shown in Cc1 and Dc1, respectively. ap: area postrema, ts: tractus solitaries, cc: central canal.
doi:10.1371/journal.pone.0050703.g006
Figure 7. Co-localization of CB1 receptors + GAD67 and CB1 receptors + glutamate immunoreactivity. Quantification of the co-
localization of CB1 receptor immunoreactivity with GAD67 and glutamate immunoreactivity in the rostrocaudal direction of the NTS (A). CB1 receptor
immunoreactivity was observed to be co-localized with significantly more GAD67-ir cells than glutamate-ir cells throughout the rostrocaudal axis. The
number of cells in which CB1 receptor immunoreactivity co-localized with both GAD67 and glutamate immunoreactivity was greater in the lateral
portion than the medial portion of the NTS (B).
doi:10.1371/journal.pone.0050703.g007
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nucleus of the vagus originating from the NTS were attenuated by
WIN 55,212-2 [11]. This study suggested that activation of CB1
receptors attenuates the release of neurotransmitters from the
terminals of NTS neurons that regulate parasympathetic motor
output [11].
Emetic stimulation has been found to inhibit the swallowing
reflex in decerebrate rats [54]. As cannabinoids inhibit emesis
[14,15,16,17], it can be assumed that cannabinoids facilitate the
swallowing reflex. In addition, leptin (a hormone secreted by
adipose tissue) has been found to inhibit the swallowing reflex by
inhibiting the activity of the premotoneurons responsible for
swallowing [28]. Leptin is a satiety signal that acts on the
hypothalamus to reduce food intake [6,55]. An inverse functional
relationship between cannabinoids and leptin has been found
where leptin administration suppresses the expression of endog-
enous cannabinoids in the hypothalamus of normal rats. While
genetically obese, chronically hyperphagic rats showed elevated
levels of endogenous cannabinoids [56]. Considered with our data,
these studies demonstrate that cannabinoids can both regulate
food intake and facilitate swallowing.
Our finding that cannabinoids can modulate the swallowing
reflex has physiological significance. It suggests that cannabinoids
regulate swallowing via the central pattern generator of swallowing
in the NTS, using the retrograde suppression of synaptic
transmission. In the biological condition, it may be possible that
endogenous cannabinoid (2-AG) is involved in the fine-tuning of
motor output from the central pattern generator of swallowing by
modulating synaptic neurotransmitter release. This phenomenon
in the central pattern generator of swallowing may controls the
daily regulation of the swallowing reflex.
In conclusion, the present study demonstrates that cannabinoids
facilitate the electrically stimulated swallowing reflex. CB1
receptors located in the central pattern generator of swallowing
in the NTS are likely to be involved in the facilitation of the
mechanism. In addition, the findings of the present study also raise
the possibility of the therapeutic use of cannabinoid ligands for
treating dysphagia (difficulty swallowing), although further studies
are required in this regard.
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